Eintrag weiter verarbeiten
Verfügbar über Online-Ressource

RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast cancer: a multicenter, confirmative, one-armed, intra-ind...

Gespeichert in:

Veröffentlicht in: BMC cancer 18(2018) Artikel-Nummer 851, 7 Seiten
Personen und Körperschaften: Heil, Jörg (VerfasserIn), Sinn, Peter (VerfasserIn), Richter, Hannah (VerfasserIn), Pfob, André (VerfasserIn), Schäfgen, Benedikt (VerfasserIn), Hennigs, André (VerfasserIn), Riedel, Fabian (VerfasserIn), Thomas, Bettina C. (VerfasserIn), Rauch, Geraldine (VerfasserIn), Golatta, Michael (VerfasserIn)
Titel: RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast cancer: a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial/ Joerg Heil, Peter Sinn, Hannah Richter, André Pfob, Benedikt Schaefgen, André Hennigs, Fabian Riedel, Bettina Thomas, Marc Thill, Markus Hahn, Jens-Uwe Blohmer, Sherko Kuemmel, Maria Margarete Karsten, Mattea Reinisch, John Hackmann, Toralf Reimer, Geraldine Rauch, Michael Golatta
Format: E-Book-Kapitel
Sprache: Englisch
veröffentlicht:
25 August 2018
Gesamtaufnahme: : BMC cancer, 18(2018) Artikel-Nummer 851, 7 Seiten
, volume:18
Elektronische Reproduktion: Heil, Jörg, 1978 - , RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer, London : Biomed Central ; Springer, 2018, 1 Online-Ressource (7 Seiten)
Quelle: Verbunddaten SWB
Lizenzfreie Online-Ressourcen
Details
Zusammenfassung: Neoadjuvant chemotherapy (NACT) is a standard approach of the multidisciplinary treatment of breast cancer. Depending on the biological subtype a pathological complete response in the breast (bpCR) can be achieved in up to 60% of the patients. However, only limited accuracy can be reached when using imaging for prediction of bpCR prior to surgery. Due to this diagnostic uncertainty, surgery after NACT is considered to be obligatory for all patients in order to either completely remove residual disease or to diagnose a bpCR histologically. The purpose of this trial is to evaluate the accuracy of a vacuum-assisted biopsy (VAB) to diagnose a bpCR after NACT prior to surgery.
Beschreibung: Gesehen am 25.09.2018
ISSN: 1471-2407
DOI: 10.1186/s12885-018-4760-4